Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus

Comparative Hepatology

Volumn 4, Issue , 2005, Pages

  Halfon, Philippe ^a   Bourlière, Marc ^b   Pénaranda, Guillaume ^a   Deydier, Romaric ^a   Renou, Christophe ^c   Botta Fridlund, Danielle ^d   Tran, Albert ^e   Portal, Isabelle ^d   Allemand, Isabelle ^d   Rosenthal Allieri, Alessandra ^e   Ouzan, Denis ^f  

^a Laboratoire Alphabio   (France)

^b HÔPITAL SAINT JOSEPH   (France)

^c Hyeres Hospital   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f INSTITUT ARNAULT TZANCK   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYALURONIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; PREDICTION; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

EID: 26844518836     PISSN: 14765926     EISSN: 14765926     Source Type: Journal    
DOI: 10.1186/1476-5926-4-6     Document Type: Article

References (27)

1. Parillo R: Long term effect of antiviral therapy on liver histology in chronic hepatitis C. EASL; 2004.
2. Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M, Caballeria J, Ballesta AM, Rodes J: Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996, 24(6):1399-1403.
3. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, Gallois Y, Rifflet H, Maiga MY, Penneau-Fontbonne D, Cales P: Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997, 113(5):1609-1616.
4. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38(2):518-526.
5. Cadranel JF: [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]. Gastroenterol Clin Biol 2002, 26(10):823-824.
6. Guechot J, Loria A, Serfaty L, Giral P, Giboudeau J, Poupon R: Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. J Hepatol 1995, 22(1):22-26.
7. Gibson PR, Fraser JR, Brown TJ, Finch CF, Jones PA, Colman JC, Dudley FJ: Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology 1992, 15(6):1054-1059.
8. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J: Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002, 36(4 Pt 1):986-992.
9. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001, 357(9262):1069-1075.
10. Poupon RE, Balkau B, Guechot J, Heintzmann F: Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. Hepatology 1994, 19(3):635-640.
11. Korner T, Kropf J, Gressner AM: Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol 1996, 25(5):684-688.
12. Benlloch S, Berenguer M, Prieto M, Rayon JM, Aguilera V, Berenguer J: Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index. Liver Transpl 2005, 11(4):456-462.
13. Silva IS, Ferraz ML, Perez RM, Lanzoni VP, Figueiredo VM, Silva AE: Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2004, 19(3):314-318.
14. Lu LG, Zeng MD, Wan MB, Li CZ, Mao YM, Li JQ, Qiu DK, Cao AP, Ye J, Cai X, Chen CW, Wang JY, Wu SM, Zhu JS, Zhou XQ: Grading and staging of hepatic fibrosis, and its relationship with non-invasive diagnostic parameters. World J Gastroenterol 2003, 9(11):2574-2578.
15. Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B: Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004, 3(1):8.
16. Guechot J, Poupon RE, Giral P, Balkau B, Giboudeau J, Poupon R: Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 1994, 20(3):388-393.
17. Santos VN, Leite-Mor MM, Kondo M, Martins JR, Nader H, Lanzoni VP, Parise ER: Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Braz J Med Biol Res 2005, 38(5):747-753.
18. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J: Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996, 42(4):558-563.
19. El-Gindy I, El Rahman AT, El-Alim MA, Zaki SS: Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease. Egypt J Immunol 2003, 10(1):27-35.
20. Wang H, Mengsteab S, Tag CG, Gao CF, Hellerbrand C, Lammert F, Gressner AM, Weiskirchen R: Transforming growth factorbeta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol 2005, 11(13):1929-1936.
21. Lindqvist U, Laurent TC: Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest 1992, 52(7):613-621.
22. Patel K, Gordon SC, Jacobson I, Hezode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG: Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004, 41(6):935-942.
23. Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ: Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004, 127(6):1704-1713.
24. McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, Tong MJ: Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000, 15(8):945-951.
25. Bedossa P, Dargere D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38(6):1449-1457.
26. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994, 20(1 Pt 1):15-20.
27. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24(2):289-293.